 | • レポートコード：MRC2Q12-19270 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、脳神経外科治療薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 脳神経外科治療薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 脳神経外科治療薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 脳神経外科治療薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの脳神経外科治療薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の脳神経外科治療薬の売上および2028年までの予測に焦点を当てています。 脳神経外科治療薬のグローバル主要企業には、Pfizer、AstraZeneca、Biogen、Jhonson & Jhonson、ABBVIE、Takeda Pharmaceuticals、UCB、IPSEN、Standigm、BlueStar Genomic、Tonix Pharmaceuticals、BlackThorn Therapeutics、Quentrix、Wren Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 脳神経外科治療薬市場は、タイプとアプリケーションによって区分されます。世界の脳神経外科治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、液剤、カプセル剤、その他 【アプリケーション別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 脳神経外科治療薬製品概要 - タイプ別市場（錠剤、液剤、カプセル剤、その他） - アプリケーション別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の脳神経外科治療薬販売量予測2017-2028 - 世界の脳神経外科治療薬売上予測2017-2028 - 脳神経外科治療薬の地域別販売量 - 脳神経外科治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別脳神経外科治療薬販売量 - 主要メーカー別脳神経外科治療薬売上 - 主要メーカー別脳神経外科治療薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、液剤、カプセル剤、その他） - 脳神経外科治療薬のタイプ別販売量 - 脳神経外科治療薬のタイプ別売上 - 脳神経外科治療薬のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、その他） - 脳神経外科治療薬のアプリケーション別販売量 - 脳神経外科治療薬のアプリケーション別売上 - 脳神経外科治療薬のアプリケーション別価格 ・北米市場 - 北米の脳神経外科治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の脳神経外科治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの脳神経外科治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の脳神経外科治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の脳神経外科治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の脳神経外科治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の脳神経外科治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の脳神経外科治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの脳神経外科治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の脳神経外科治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、AstraZeneca、Biogen、Jhonson & Jhonson、ABBVIE、Takeda Pharmaceuticals、UCB、IPSEN、Standigm、BlueStar Genomic、Tonix Pharmaceuticals、BlackThorn Therapeutics、Quentrix、Wren Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 脳神経外科治療薬の産業チェーン分析 - 脳神経外科治療薬の原材料 - 脳神経外科治療薬の生産プロセス - 脳神経外科治療薬の販売及びマーケティング - 脳神経外科治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 脳神経外科治療薬の産業動向 - 脳神経外科治療薬のマーケットドライバー - 脳神経外科治療薬の課題 - 脳神経外科治療薬の阻害要因 ・主な調査結果 |
Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Neurosurgery Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Neurosurgery Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Neurosurgery Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Neurosurgery Drug include Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Neurosurgery Drug manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Neurosurgery Drug market. Further, it explains the major drivers and regional dynamics of the global Neurosurgery Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Neurosurgery Drug Segment by Type
Tablets
Solution
Capsules
Others
Neurosurgery Drug Segment by Application
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Neurosurgery Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Neurosurgery Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Neurosurgery Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neurosurgery Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurosurgery Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Neurosurgery Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Neurosurgery Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurosurgery Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neurosurgery Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurosurgery Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Neurosurgery Drug Product Introduction
1.2 Market by Type
1.2.1 Global Neurosurgery Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Solution
1.2.4 Capsules
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurosurgery Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurosurgery Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Neurosurgery Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurosurgery Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurosurgery Drug Sales by Region
2.4.1 Global Neurosurgery Drug Sales by Region (2017-2022)
2.4.2 Global Sales Neurosurgery Drug by Region (2023-2028)
2.5 Global Neurosurgery Drug Revenue by Region
2.5.1 Global Neurosurgery Drug Revenue by Region (2017-2022)
2.5.2 Global Neurosurgery Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurosurgery Drug Sales by Manufacturers
3.1.1 Global Top Neurosurgery Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Neurosurgery Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurosurgery Drug in 2021
3.2 Global Neurosurgery Drug Revenue by Manufacturers
3.2.1 Global Neurosurgery Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurosurgery Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurosurgery Drug Revenue in 2021
3.3 Global Neurosurgery Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurosurgery Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurosurgery Drug Sales by Type
4.1.1 Global Neurosurgery Drug Historical Sales by Type (2017-2022)
4.1.2 Global Neurosurgery Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurosurgery Drug Sales Market Share by Type (2017-2028)
4.2 Global Neurosurgery Drug Revenue by Type
4.2.1 Global Neurosurgery Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Neurosurgery Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurosurgery Drug Revenue Market Share by Type (2017-2028)
4.3 Global Neurosurgery Drug Price by Type
4.3.1 Global Neurosurgery Drug Price by Type (2017-2022)
4.3.2 Global Neurosurgery Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurosurgery Drug Sales by Application
5.1.1 Global Neurosurgery Drug Historical Sales by Application (2017-2022)
5.1.2 Global Neurosurgery Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurosurgery Drug Sales Market Share by Application (2017-2028)
5.2 Global Neurosurgery Drug Revenue by Application
5.2.1 Global Neurosurgery Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Neurosurgery Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurosurgery Drug Revenue Market Share by Application (2017-2028)
5.3 Global Neurosurgery Drug Price by Application
5.3.1 Global Neurosurgery Drug Price by Application (2017-2022)
5.3.2 Global Neurosurgery Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurosurgery Drug Market Size by Type
6.1.1 North America Neurosurgery Drug Sales by Type (2017-2028)
6.1.2 North America Neurosurgery Drug Revenue by Type (2017-2028)
6.2 North America Neurosurgery Drug Market Size by Application
6.2.1 North America Neurosurgery Drug Sales by Application (2017-2028)
6.2.2 North America Neurosurgery Drug Revenue by Application (2017-2028)
6.3 North America Neurosurgery Drug Market Size by Country
6.3.1 North America Neurosurgery Drug Sales by Country (2017-2028)
6.3.2 North America Neurosurgery Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Neurosurgery Drug Market Size by Type
7.1.1 Europe Neurosurgery Drug Sales by Type (2017-2028)
7.1.2 Europe Neurosurgery Drug Revenue by Type (2017-2028)
7.2 Europe Neurosurgery Drug Market Size by Application
7.2.1 Europe Neurosurgery Drug Sales by Application (2017-2028)
7.2.2 Europe Neurosurgery Drug Revenue by Application (2017-2028)
7.3 Europe Neurosurgery Drug Market Size by Country
7.3.1 Europe Neurosurgery Drug Sales by Country (2017-2028)
7.3.2 Europe Neurosurgery Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurosurgery Drug Market Size by Type
8.1.1 Asia Pacific Neurosurgery Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurosurgery Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Neurosurgery Drug Market Size by Application
8.2.1 Asia Pacific Neurosurgery Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurosurgery Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Neurosurgery Drug Market Size by Region
8.3.1 Asia Pacific Neurosurgery Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurosurgery Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neurosurgery Drug Market Size by Type
9.1.1 Latin America Neurosurgery Drug Sales by Type (2017-2028)
9.1.2 Latin America Neurosurgery Drug Revenue by Type (2017-2028)
9.2 Latin America Neurosurgery Drug Market Size by Application
9.2.1 Latin America Neurosurgery Drug Sales by Application (2017-2028)
9.2.2 Latin America Neurosurgery Drug Revenue by Application (2017-2028)
9.3 Latin America Neurosurgery Drug Market Size by Country
9.3.1 Latin America Neurosurgery Drug Sales by Country (2017-2028)
9.3.2 Latin America Neurosurgery Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Neurosurgery Drug Market Size by Type
10.1.1 Middle East and Africa Neurosurgery Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurosurgery Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurosurgery Drug Market Size by Application
10.2.1 Middle East and Africa Neurosurgery Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurosurgery Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurosurgery Drug Market Size by Country
10.3.1 Middle East and Africa Neurosurgery Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurosurgery Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Biogen
11.3.1 Biogen Corporation Information
11.3.2 Biogen Overview
11.3.3 Biogen Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biogen Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Recent Developments
11.4 Jhonson & Jhonson
11.4.1 Jhonson & Jhonson Corporation Information
11.4.2 Jhonson & Jhonson Overview
11.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Jhonson & Jhonson Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jhonson & Jhonson Recent Developments
11.5 ABBVIE
11.5.1 ABBVIE Corporation Information
11.5.2 ABBVIE Overview
11.5.3 ABBVIE Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ABBVIE Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ABBVIE Recent Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Corporation Information
11.6.2 Takeda Pharmaceuticals Overview
11.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Pharmaceuticals Recent Developments
11.7 UCB
11.7.1 UCB Corporation Information
11.7.2 UCB Overview
11.7.3 UCB Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 UCB Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UCB Recent Developments
11.8 IPSEN
11.8.1 IPSEN Corporation Information
11.8.2 IPSEN Overview
11.8.3 IPSEN Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 IPSEN Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IPSEN Recent Developments
11.9 Standigm
11.9.1 Standigm Corporation Information
11.9.2 Standigm Overview
11.9.3 Standigm Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Standigm Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Standigm Recent Developments
11.10 BlueStar Genomic
11.10.1 BlueStar Genomic Corporation Information
11.10.2 BlueStar Genomic Overview
11.10.3 BlueStar Genomic Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BlueStar Genomic Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BlueStar Genomic Recent Developments
11.11 Tonix Pharmaceuticals
11.11.1 Tonix Pharmaceuticals Corporation Information
11.11.2 Tonix Pharmaceuticals Overview
11.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tonix Pharmaceuticals Recent Developments
11.12 BlackThorn Therapeutics
11.12.1 BlackThorn Therapeutics Corporation Information
11.12.2 BlackThorn Therapeutics Overview
11.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BlackThorn Therapeutics Recent Developments
11.13 Quentrix
11.13.1 Quentrix Corporation Information
11.13.2 Quentrix Overview
11.13.3 Quentrix Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Quentrix Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Quentrix Recent Developments
11.14 Wren Pharmaceuticals
11.14.1 Wren Pharmaceuticals Corporation Information
11.14.2 Wren Pharmaceuticals Overview
11.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Wren Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurosurgery Drug Industry Chain Analysis
12.2 Neurosurgery Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurosurgery Drug Production Mode & Process
12.4 Neurosurgery Drug Sales and Marketing
12.4.1 Neurosurgery Drug Sales Channels
12.4.2 Neurosurgery Drug Distributors
12.5 Neurosurgery Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurosurgery Drug Industry Trends
13.2 Neurosurgery Drug Market Drivers
13.3 Neurosurgery Drug Market Challenges
13.4 Neurosurgery Drug Market Restraints
14 Key Findings in The Global Neurosurgery Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer